PWAM
PRCT icon

Private Wealth Asset Management’s Procept Biorobotics PRCT Stock Holding History

Private Wealth Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$452 Hold
20
– – ﹤0.01% 909
2026
Q1 		$500 Hold
20
– – ﹤0.01% 899
2025
Q4 		$629 Hold
20
– – ﹤0.01% 884
2025
Q3 		$714 Buy
+20
New +$913 ﹤0.01% 871

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Private Wealth Asset Management's PRCT Position: Q2 2026 in Review

Private Wealth Asset Management held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 20 shares worth $452. The position accounts for ﹤0.01% of the portfolio, ranked #909.

Private Wealth Asset Management first reported a position in PRCT in Q3 2025 and has held it in 4 quarters since. The position peaked at $714 in Q3 2025. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Private Wealth Asset Management held 20 shares of Procept Biorobotics worth $452 as of Q2 2026.
  • Private Wealth Asset Management left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Private Wealth Asset Management's portfolio in Q2 2026, its #909 holding.
  • Private Wealth Asset Management first reported a position in Procept Biorobotics in Q3 2025 and has held it in 4 quarters since.
  • Private Wealth Asset Management's Procept Biorobotics position peaked at $714 in Q3 2025.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Private Wealth Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.